Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Asian Paints Ltd. M&A Activity 2026

Mar 24, 2026

59121_rns_2026-03-24_7f4cfe0b-7774-4dc1-98b1-19925afaa71d.pdf

M&A Activity

Open in viewer

Opens in your device viewer

==> picture [115 x 84] intentionally omitted <==

==> picture [104 x 79] intentionally omitted <==

APL/SEC/57/2025-26/29

24[th] March 2026

BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 Security Code: 500820

National Stock Exchange of India Limited Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (East), Mumbai – 400 051 Symbol: ASIANPAINT

Sir/Madam,

Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) – Scheme of Amalgamation between Subsidiary Companies

This is to inform you that the Board of Directors of Harind Chemicals and Pharmaceuticals Private Limited (“Harind”), a subsidiary of the Company, and Nova Surface-Care Centre Private Limited (“Nova”), a wholly-owned subsidiary of Harind, at their respective meetings held today i.e., Tuesday, 24[th] March 2026, have, inter alia , approved the Scheme of Amalgamation of Nova (“Transferor Company”) with Harind ("Transferee Company") subject to approval of the regulatory authorities.

The said Scheme of Amalgamation is not expected to have any material impact on the financials of the Company.

In compliance with Regulation 30 of the Listing Regulations, read with the applicable SEBI circulars, the requisite information is appended and marked as Annexure A.

The Company will make necessary disclosures on any material developments in this regard, from time to time.

You are requested to take the above information on record.

Thanking you,

Yours truly,

For ASIAN PAINTS LIMITED

JEYAMURUGAN Digitally signed by JEYAMURUGAN RAMALINGAM RAMALINGAM JEYAPANDIYAN JEYAPANDIYAN Date: 2026.03.24 21:22:44 +05'30'

R J JEYAMURUGAN CFO & COMPANY SECRETARY

Encl.: As above

==> picture [596 x 51] intentionally omitted <==

==> picture [115 x 84] intentionally omitted <==

==> picture [104 x 79] intentionally omitted <==

ANNEXURE A

ANNEXURE A ANNEXURE A ANNEXURE A
Sl.
No.
Particulars Disclosure
a) Name of the entity(ies)
forming part of the
amalgamation/merger,
details in brief such as
size, turnover, etc.
Transferor Company:Nova Surface-Care Centre Private Limited (‘‘Nova’’) is
a private limited company incorporated on 7thSeptember 2011.
Transferee Company:Harind Chemicals and Pharmaceuticals Private
Limited (“Harind’’) is a private limited company incorporated on 6thJune 1995.
Nova is a wholly-owned subsidiary of Harind.
Asian Paints Limited (“the Company”) holds 51% stake in Harind, making
Harind and Nova, subsidiary companies of the Company.
(Rs. in crores)
Name of the Entities
Net worth as of
31.03.2025
Turnover as of
31.03.2025
Nova
0.49
0.08
Harind
18.81
37.87
Name of the Entities Net worth as of
31.03.2025
Turnover as of
31.03.2025
Nova 0.49 0.08
Harind 18.81 37.87
b) Whether
the
transaction would fall
within
related
party
transactions? If yes,
whether the same is
done at“arm’s length”.
Yes, it is a related party transaction as Harind and Nova are subsidiaries of the
Company. The said transaction is in ordinary course of business and at arm’s
length.
The requisite approvals for the aforementioned related party transaction have
been duly obtained from the Audit Committee of the Company.
c) Area of business of the
entity(ies)
Transferor Company:Nova is engaged in the business of testing services of
paints and related chemicals.
Transferee
Company:
Harind
is
engaged
in
the
business
of
manufacturing/dealing in chemical and other related products related to paints.
d) Rationale
for
amalgamation/ merger
-
Nova’s existing laboratory capacity for testing is exclusively being used by
Harind, with minimal commercial engagements with other third-party
entities. Given that, operating Nova as a separate standalone entity is no
longer strategically necessary.
-
Amalgamating Nova with Harind will streamline operations and align the
business structure with its intended purpose, resulting in greater
operational and strategic coherence.
-
It will lead to reduction in the multiplicity of legal and regulatory
compliances, generate economies in administrative costs and facilitate
consolidation to enable effective management.
e) In
case
of
cash
consideration

amount or otherwise
share exchange ratio
There is no consideration involved. The entire share capital of Nova is held by
Harind and its nominees. Accordingly, upon the Scheme of Amalgamation
becoming effective, all equity shares issued by Nova shall stand cancelled and
extinguished.
f) Brief details of change
in
shareholding
pattern (if any) of the
listed entity
Not applicable.

==> picture [596 x 51] intentionally omitted <==